Results 131 to 140 of about 2,103,170 (215)

Prognostic significance of the neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma treated with proton beam therapy. [PDF]

Radiat Oncol J
Makita K, Hojo H, Hirata H, Dey T, Nakamura M, Fujisawa T, Kotani D, Wakabayashi M, Oyoshi H, Tomizawa K, Zhou Y, Koike Y, Uchida G, Mishima S, Kojima T, Zenda S.   +15 more
europepmc   +1 more source

Exploratory analysis of HER2-positive/CLDN18.2-positive metastatic gastric and gastroesophageal junction cancer toward future therapeutic development. [PDF]

ESMO Gastrointest Oncol
Okemoto D, Nakayama I, Shitara K.
europepmc   +1 more source

Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study. [PDF]

Breast Cancer Res Treat
Masuda N, Yasojima H, Bando H, Yamanaka T, Shigematsu H, Takahashi M, Nagai SE, Ito M, Aruga T, Tokiwa M, Imoto S, Nakamura R, Ishiguro H, Kawabata H, Saji S, Haga H, Morita S, Toi M.   +17 more
europepmc   +1 more source

Cycloastragenol Inhibits Colorectal Cancer Cell Metastasis via Epithelial-Mesenchymal Transition and the PI3K Signalling Pathway. [PDF]

J Cell Mol Med
Miao J, Feng P.
europepmc   +1 more source

Assessing antimicrobial resistance inclusion in pre-service pharmacy training curricula of five selected sub-Saharan African universities: challenges and opportunities. [PDF]

BMC Med Educ
Omoniyei L, Damilola A, Odhiambo J, Nsongurua U, Babatunde Y, Mawufemor AS, Francis J, Ismail S, Awolola O, Hamza H, Akpan S, Majekodunmi AO, Mbadiwe E.   +12 more
europepmc   +1 more source

Smart adsorbent frameworks enabling high-efficiency pharmaceutical degradation <i>via</i> adsorption. [PDF]

RSC Adv
Islam M, Khan ZUH, Islam A, Khasim S, Ahmad F, Ahmad N, Alsayer IA.   +6 more
europepmc   +1 more source

Development of Second Primary Malignancies in Long-term Survivors of Unresectable Esophageal Cancer. [PDF]

Cancer Diagn Progn
Watanabe R, Mitani S, Okura M, Inagaki C, Tanizaki J, Tanaka K, Iwasa T, Yonesaka K, Hayashi H.   +8 more
europepmc   +1 more source

Model-Informed Drug Development: Addressing the Critical Need for Training in the Promising New Field. [PDF]

Dela J Public Health
Moghadamnia Y, Zurakowski R, Islam MA.
europepmc   +1 more source

Correction to "Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical Properties". [PDF]

ACS Med Chem Lett
Mahmood SU, Boddu RK, Eberhard J, Hoffman CS, Gordon J, Colussi D, Childers W, Amurrio E, Danaher M, Kelly MP, Rotella DP.   +10 more
europepmc   +1 more source

Health-related quality of life with encorafenib plus binimetinib for BRAF V600E thyroid cancer. [PDF]

Eur Thyroid J
Kiyota N, Tahara M, Imai H, Takahashi S, Nishiyama A, Tamura S, Shimizu Y, Kadowaki S, Ito KI, Hirashima Y, Ueno S, Sugitani I.   +11 more
europepmc   +1 more source